merged_africa-snakebite-treatment-access.txt
<question_number>1</question_number>
<answer>Puff adder venom destroys blood-clotting factors, causing uncontrolled bleeding and tissue necrosis that progressed despite antivenom administration.</answer>

<question_number>2</question_number>
<answer>Indian antivenom targets krait venom, while Kenyan puff adders produce region-specific hemotoxins that differ in composition, making imported antivenom ineffective.</answer>

<question_number>3</question_number>
<answer>Neurotoxins (cobras/mambas) and hemotoxins (puff adders) require distinct antibody targets; monoclonal antibodies could neutralize both toxin families universally.</answer>

<question_number>4</question_number>
<answer>Spitting cobras shoot venom into eyes, mimicking non-venomous injuries; traditional healers may misdiagnose ocular symptoms without recognizing venom exposure.</answer>

<question_number>5</question_number>
<answer>Rainy seasons flood snake habitats, increasing encounters; dry seasons drive snakes toward farms/homes for water, disproportionately affecting barefoot farmers and children.</answer>

<question_number>6</question_number>
<answer>Erect front fangs for deep injection, rapid neurotoxin action (paralysis within an hour), and high mobility (14-foot length) compared to puff adders' slower hemotoxic effects.</answer>

<question_number>7</question_number>
<answer>Antivenom requires refrigeration and IV administration; rural clinics lack cold storage and trained staff, delaying treatment beyond the critical window for pregnant victims.</answer>

<question_number>8</question_number>
<answer>Tourniquets worsen tissue damage by cutting blood flow, while traditional treatments delay proper care, increasing amputation risks despite venom's localized effects.</answer>